Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26585 | 20162621 | Hepatology | Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis. | 2010 | Details |
A26586 | 20158939 | Proc Nutr Soc | Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. | 2010 | Details |
A26588 | 20151876 | Biomarkers | Non-invasive diagnosis of liver diseases by breath analysis using an optimized ion-molecule reaction-mass spectrometry approach: a pilot study. | 2010 | Details |
A26589 | 20150538 | J Am Soc Nephrol | Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. | 2010 | Details |
A26590 | 20145609 | Am J Gastroenterol | Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. | 2010 | Details |
A26591 | 20143458 | World J Gastroenterol | Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? | 2010 | Details |
A26592 | 20142825 | Int J Obes (Lond) | Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. | 2010 | Details |
A26593 | 20138495 | J Nutr Biochem | Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. | 2010 | Details |
A26596 | 20131032 | Chin J Integr Med | Treatment of non-alcoholic fatty liver disease by Qianggan Capsule. | 2010 | Details |
A26597 | 20128971 | Zhonghua Gan Zang Bing Za Zhi | [Metabolic characteristics of a fatty liver disease model induced by high-fat feeding in young rats]. | 2010 | Details |
A26598 | 20119733 | Obes Surg | Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. | 2010 | Details |
A26599 | 20116951 | Eur J Radiol | Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy. | 2010 | Details |
A26600 | 20114046 | FEBS Lett | Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice. | 2010 | Details |
A26601 | 20112035 | Amino Acids | Methionine limitation results in increased hepatic FAS activity, higher liver 18:1 to 18:0 fatty acid ratio and hepatic TAG accumulation in Atlantic salmon, Salmo salar. | 2010 | Details |
A26602 | 20112031 | J Gastroenterol | Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. | 2010 | Details |
A26603 | 20111022 | Obesity (Silver Spring) | Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat. | 2010 | Details |
A26604 | 20108769 | Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi | [Expression and significance of liver X receptor-alpha in nonalcoholic fatty liver disease in rats]. | 2009 | Details |
A26605 | 20104187 | J Clin Gastroenterol | Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels. | 2010 | Details |
A26606 | 20101871 | Acta Clin Belg | Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics. | 2010 | Details |
A26607 | 20101745 | Hepatology | Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. | 2010 | Details |
A26608 | 20101463 | Dig Dis Sci | Nonalcoholic fatty liver disease: a review and update. | 2010 | Details |
A26609 | 20096896 | Metabolism | Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis. | 2010 | Details |
A26610 | 20096157 | Actas Dermosifiliogr | Cardiometabolic comorbidities and the approach to patients with psoriasis. | 2009 | Details |
A26611 | 20095887 | Scand J Gastroenterol | Serum chemerin and vaspin in non-alcoholic fatty liver disease. | 2010 | Details |
A26612 | 20093562 | Am J Physiol Gastrointest Liver Physiol | The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. | 2010 | Details |
A26613 | 20093511 | Radiology | Presence of coronary plaques in patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26614 | 20091629 | Cochrane Database Syst Rev | Bariatric surgery for non-alcoholic steatohepatitis in obese patients. | 2010 | Details |
A26615 | 20088867 | Liver Int | The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. | 2010 | Details |
A26616 | 20087858 | Mol Nutr Food Res | Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. | 2010 | Details |
A26617 | 20087305 | J Sports Med Phys Fitness | Aerobic exercise and non-alcoholic fatty liver disease: a case report. | 2009 | Details |
A26618 | 20085121 | Eur Rev Med Pharmacol Sci | Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. | 2010 | Details |
A26619 | 20084525 | J Gastroenterol | Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits. | 2010 | Details |
A26620 | 20082871 | Arch Med Res | High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2009 | Details |
A26622 | 20080086 | Exp Mol Pathol | The identification of stem cells in human liver diseases and hepatocellular carcinoma. | 2010 | Details |
A26623 | 20079722 | Chem Biol Interact | Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile. | 2010 | Details |
A26624 | 20079327 | Zhonghua Nei Ke Za Zhi | [Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.]. | 2009 | Details |
A26625 | 20078219 | Annu Rev Pathol | Nonalcoholic fatty liver disease: pathology and pathogenesis. | 2010 | Details |
A26626 | 20076826 | J Gastrointestin Liver Dis | Two cases of non-alcoholic steato-hepatitis developing from simple fatty liver. | 2009 | Details |
A26627 | 20074156 | J Gastroenterol Hepatol | Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. | 2010 | Details |
A26628 | 20066503 | Obes Surg | Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. | 2010 | Details |
A26629 | 20064693 | Med Hypotheses | Impact of ecology on development of NIDDM. | 2010 | Details |
A26630 | 20064512 | Gastroenterology | SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. | 2010 | Details |
A26631 | 20059344 | Annu Rev Med | Emerging molecular targets for the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
A26633 | 20049084 | Ger Med Sci | Hepatology - Guidelines on Parenteral Nutrition, Chapter 16. | 2009 | Details |
A26634 | 20049074 | Ger Med Sci | Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11. | 2009 | Details |
A26635 | 20045153 | Metabolism | Plasma apelin levels in subjects with nonalcoholic fatty liver disease. | 2009 | Details |
A26636 | 20043871 | Biochem Biophys Res Commun | Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease. | 2009 | Details |
A26637 | 20043126 | Int J Mol Med | Long-term feeding of a synthetic diet rich in disaccharides induces hepatic fibrosis in nonalcoholic fatty liver disease in Zucker rats. | 2010 | Details |
A26638 | 20042103 | Lipids Health Dis | Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. | 2009 | Details |
A26639 | 25197510 | Middle East J Dig Dis | Hepatocellular carcinoma in the world and the middle East. | 2010 | Details |
A26640 | 25197507 | Middle East J Dig Dis | Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study. | 2010 | Details |
A26641 | 25197505 | Middle East J Dig Dis | The effect of weight reduction on ultrasonographic findings of nonalcoholic Fatty liver. | 2010 | Details |
A26642 | 24149634 | J Sports Sci Med | Association of cardiorespiratory fitness with elevated hepatic enzyme and liver fat in Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus. | 2010 | Details |
A26643 | 23105881 | Indian J Clin Biochem | Role of plasma amino acids and gaba in alcoholic and non-alcoholic fatty liver disease-a pilot study. | 2010 | Details |
A26644 | 22308119 | Hepat Mon | N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease. | 2010 | Details |
A26645 | 21560616 | Eksp Klin Gastroenterol | [Liver fibroelastometria in the elderly patients]. | 2010 | Details |
A26646 | 21525763 | Dig Dis | Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis. | 2011 | Details |
A26647 | 21525758 | Dig Dis | Gut-liver axis and sensing microbes. | 2011 | Details |
A26648 | 21525755 | Dig Dis | Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways. | 2011 | Details |
A26649 | 21525754 | Dig Dis | Long-term, clinical follow-up in fatty liver patients. | 2011 | Details |
A26650 | 21442055 | Hepatol Int | Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. | 2010 | Details |
A26651 | 21387764 | Przegl Lek | [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers]. | 2010 | Details |
A26652 | 20041406 | Hepatology | Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. | 2010 | Details |
A26653 | 20040915 | Am J Gastroenterol | Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". | 2009 | Details |
A26654 | 20040336 | Int J Clin Pharmacol Ther | Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway. | 2010 | Details |
A26655 | 20039768 | Arch Iran Med | A modification of the Brunt system for scoring liver histology of patients with non-alcoholic fatty liver disease. | 2010 | Details |
A26656 | 20038265 | Immunopharmacol Immunotoxicol | Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. | 2010 | Details |
A26657 | 20036859 | Front Biosci (Elite Ed) | Biochemical characteristics and risk factors in non-alcoholic fatty liver. | 2010 | Details |
A26658 | 20033846 | Dig Dis Sci | Phenotypic characteristics and diagnoses of patients referred to an iron overload clinic. | 2009 | Details |
A26659 | 20033348 | Obes Surg | SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. | 2009 | Details |
A26660 | 20032580 | J Atheroscler Thromb | Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. | 2009 | Details |
A26661 | 20030578 | Scand J Gastroenterol | Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome. | 2010 | Details |
A26662 | 20028551 | Diabetol Metab Syndr | Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents. | 2009 | Details |
A26663 | 20027673 | World J Gastroenterol | Genetic polymorphisms in non-alcoholic fatty liver disease: clues to pathogenesis and disease progression. | 2009 | Details |
A26664 | 20027672 | World J Gastroenterol | Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. | 2009 | Details |
A26665 | 20026019 | Clin Chim Acta | Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. | 2009 | Details |
A26666 | 20025483 | Pathology | Olive leaf extract prevents spontaneous occurrence of non-alcoholic steatohepatitis in SHR/NDmcr-cp rats. | 2010 | Details |
A26667 | 20022856 | Adv Med Sci | Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. | 2009 | Details |
A26668 | 20022654 | J Hepatol | Risk of HCC: genetic heterogeneity and complex genetics. | 2009 | Details |
A26669 | 20022466 | Nutrition | Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. | 2009 | Details |
A26670 | 20015565 | J Hepatol | The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. | 2009 | Details |
A26671 | 20014489 | Zhejiang Da Xue Xue Bao Yi Xue Ban | [An in vitro hepatic steatosis cell model for study of non-alcoholic fatty liver disease]. | 2009 | Details |
A26672 | 20014114 | Hepatology | Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. | 2010 | Details |
A26673 | 20010099 | Curr Opin Gastroenterol | Implications of diet on nonalcoholic fatty liver disease. | 2010 | Details |
A26674 | 20009132 | Ann Hepatol | Altered clot kinetics in patients with non-alcoholic fatty liver disease. | 2010 | Details |
A26675 | 20002475 | Diabet Med | Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. | 2009 | Details |
A26676 | 20002471 | Diabet Med | Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. | 2009 | Details |
A26677 | 20001571 | Gynecol Endocrinol | Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role? | 2010 | Details |
A26678 | 20001159 | Rev Esp Enferm Dig | Acquired chronic hepatocerebral degeneration due to cirrhosis from non-alcoholic steatohepatitis. | 2009 | Details |
A26679 | 19961393 | Clin Chem Lab Med | Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. | 2010 | Details |
A26680 | 19961041 | Eur Rev Med Pharmacol Sci | Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease. | 2010 | Details |
A26681 | 19960252 | Dig Dis Sci | The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. | 2009 | Details |
A26682 | 19958640 | Zhonghua Gan Zang Bing Za Zhi | [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease]. | 2009 | Details |
A26683 | 19958638 | Zhonghua Gan Zang Bing Za Zhi | [Clinical and histological features of non-alcoholic fatty liver disease]. | 2009 | Details |
A26684 | 19957147 | Methods Mol Biol | Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new? | 2010 | Details |
A26685 | 19957049 | Obes Surg | Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass. | 2009 | Details |
A26686 | 19956652 | PLoS One | Alleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout mice. | 2009 | Details |
A26687 | 19951280 | Am J Transplant | Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients. | 2009 | Details |
A26688 | 19948621 | Pediatrics | Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. | 2009 | Details |
A26689 | 19948145 | Curr Biol | An emerging role of mTOR in lipid biosynthesis. | 2009 | Details |